625 related articles for article (PubMed ID: 29917301)
1. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
[TBL] [Abstract][Full Text] [Related]
2. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
Verheyen N; Schmid J; Kolesnik E; Schwegel N; Späth J; Kattnig L; Riepl H; Zach D; Santner V; Höller V; Pilz S; Tomaschitz A; Fuchsjäger M; Fahrleitner-Pammer A; Dimai HP; Obermayer-Pietsch B; Fruhwald F; Scherr D; Zirlik A; von Lewinski D; Ablasser K
ESC Heart Fail; 2024 Jun; 11(3):1730-1738. PubMed ID: 38450879
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone receptor antagonists decrease mortality and cardiovascular hospitalizations in chronic heart failure with reduced left ventricular ejection fraction, but not in chronic heart failure with preserved left ventricular ejection fraction: a meta-analysis of randomized controlled trials.
DE Vecchis R; Ariano C
Minerva Cardioangiol; 2017 Aug; 65(4):427-442. PubMed ID: 27958695
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors and Outcomes Associated With Heart Failure With Preserved and Reduced Ejection Fraction in People With Chronic Kidney Disease.
Bansal N; Zelnick LR; Scherzer R; Estrella M; Shlipak MG
Circ Heart Fail; 2024 May; 17(5):e011173. PubMed ID: 38742428
[TBL] [Abstract][Full Text] [Related]
6. Heart failure outcomes by left ventricular ejection fraction in a contemporary region-wide patient cohort.
Sundström J; Ärnlöv J; Karayiannides S; Bodegard J; Ersmark K; Gustafsson S; Cars T; Svensson MK; Norhammar A
ESC Heart Fail; 2024 Jun; 11(3):1377-1388. PubMed ID: 38311878
[TBL] [Abstract][Full Text] [Related]
7. Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.
Gupta DK; Shah AM; Castagno D; Takeuchi M; Loehr LR; Fox ER; Butler KR; Mosley TH; Kitzman DW; Solomon SD
JACC Heart Fail; 2013 Apr; 1(2):156-63. PubMed ID: 23671819
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults.
Zhao L; Zierath R; John JE; Claggett BL; Hall ME; Clark D; Butler KR; Correa A; Shah AM
JAMA Netw Open; 2022 Sep; 5(9):e2231878. PubMed ID: 36107422
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus does not alter mortality or hospitalisation risk in patients with newly diagnosed heart failure with preserved ejection fraction: Time to rethink pathophysiological models of disease progression.
Gierula J; Straw S; Cole CA; Lowry JE; Paton MF; McGinlay M; Witte KK; Grant PJ; Wheatcroft SB; Drozd M; Slater TA; Cubbon RM; Kearney MT
Diab Vasc Dis Res; 2024; 21(2):14791641231224241. PubMed ID: 38623877
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis.
Teramoto K; Santos M; Claggett B; John JE; Solomon SD; Kitzman D; Folsom AR; Cushman M; Matsushita K; Skali H; Shah AM
PLoS Med; 2020 Oct; 17(10):e1003361. PubMed ID: 33057391
[TBL] [Abstract][Full Text] [Related]
11. Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance.
Pandey A; Vaduganathan M; Arora S; Qamar A; Mentz RJ; Shah SJ; Chang PP; Russell SD; Rosamond WD; Caughey MC
Circulation; 2020 Jul; 142(3):230-243. PubMed ID: 32486833
[TBL] [Abstract][Full Text] [Related]
12. Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life.
Vu K; Claggett BL; John JE; Skali H; Solomon SD; Mosley TH; Williams JE; Kucharska-Newton A; Biering-Sørensen T; Shah AM
J Am Heart Assoc; 2021 Dec; 10(23):e020094. PubMed ID: 34796739
[TBL] [Abstract][Full Text] [Related]
13. Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk.
Miller RJH; Nabipoor M; Youngson E; Kotrri G; Fine NM; Howlett JG; Paterson ID; Ezekowitz J; McAlister FA
ESC Heart Fail; 2022 Jun; 9(3):1564-1573. PubMed ID: 35261203
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognosis of patients with hypertrophic cardiomyopathy and heart failure with preserved ejection fraction.
Chen QF; Hu J; Hu J; Nijjar PS; Xu J; Shi S; Liang D; Liao H; Gao J; Lin WH; You S; Zhou XD
Clin Res Cardiol; 2024 May; 113(5):761-769. PubMed ID: 38197895
[TBL] [Abstract][Full Text] [Related]
15. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
[TBL] [Abstract][Full Text] [Related]
16. Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology Registry.
Bae JP; Kallenbach L; Nelson DR; Lavelle K; Winer-Jones JP; Bonafede M; Murakami M
BMC Endocr Disord; 2024 May; 24(1):59. PubMed ID: 38693484
[TBL] [Abstract][Full Text] [Related]
17. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.
John JE; Claggett B; Skali H; Solomon SD; Cunningham JW; Matsushita K; Konety SH; Kitzman DW; Mosley TH; Clark D; Chang PP; Shah AM
J Am Heart Assoc; 2022 Sep; 11(17):e021660. PubMed ID: 36000416
[TBL] [Abstract][Full Text] [Related]
18. Preclinical systolic dysfunction relating to ankle-brachial index among high-risk PAD population with preserved left ventricular ejection fraction.
Lin YH; Sung KT; Tsai CT; Lai YH; Lo CI; Yu FC; Lan WR; Hung TC; Kuo JY; Hou CJ; Yen CH; Peng MC; Yeh HI; Wu MT; Hung CL
Sci Rep; 2024 Mar; 14(1):6145. PubMed ID: 38480756
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives.
Kessler EL; Oerlemans MIFJ; van den Hoogen P; Yap C; Sluijter JPG; de Jager SCA
J Cardiovasc Transl Res; 2021 Feb; 14(1):63-74. PubMed ID: 32444946
[TBL] [Abstract][Full Text] [Related]
20. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
Echouffo-Tcheugui JB; Ogunmoroti O; Golden SH; Bertoni AG; Mongraw-Chaffin M; Pandey A; Ndumele CE; Michos ED
J Card Fail; 2022 Nov; 28(11):1593-1603. PubMed ID: 35114382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
